Recherche
-
Validation d’une échelle de mesure de l’adhésion médicamenteuse cardiovasculaire utilisable en contexte hospitalier
(Annales Pharmaceutiques Françaises, 2020-02-11)Article de revueLibre accès -
Sequential mutational evaluation of CALR -mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression
(British Journal of Haematology. vol. 188, n° 6, pp. 935–944, 2020)Article de revue -
Diagnosis and management of heparin-induced thrombocytopenia
(Anaesthesia Critical Care & Pain Medicine. vol. 39, n° 2, pp. 291–310, 2020-04-20)Article de revueLibre accès -
Characterization of acute kidney injury in critically ill patients with severe coronavirus disease 2019
(Clinical Kidney Journal. pp. sfaa099, 2020-08-19)Article de revueLibre accès -
Blood-brain barrier genetic disruption leads to protective barrier formation at the Glia Limitans.
(Plos Biology. vol. 18, n° 11, pp. e3000946, 2020-01-01)Article de revueLibre accès -
Therapies targeting Frizzled‐7/β‐catenin pathway prevent the development of pathological angiogenesis in an ischemic retinopathy model
(The FASEB Journal. vol. 34, n° 1, pp. 1288–1303, 2020-08-14)Article de revueAccès réservé -
Management and outcomes of 27 pregnancies in women with myeloproliferative neoplasms
(The Journal of Maternal-Fetal & Neonatal Medicine. vol. 33, n° 1, pp. 49–56, 2020)Article de revueAccès réservé -
Chronic kidney disease of unknown origin in agricultural communities: beyond tropical mist?
(Nephrology Dialysis Transplantation, 2020-10-27)Article de revueLibre accès -
Long-term follow-up of JAK2 exon 12 polycythemia vera: a French Intergroup of Myeloproliferative Neoplasms (FIM) study.
(Leukemia, 2020-07-21)Article de revue -
Hospital medication adherence scale development in cardiovascular disorders
(Annales Pharmaceutiques Françaises, 2020-12-10)Article de revueLibre accès